Biogen
BIIB
BIIB
1,011 hedge funds and large institutions have $59.3B invested in Biogen in 2016 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 338 increasing their positions, 398 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,011
Holders Change
+47
Holders Change %
+4.88%
% of All Funds
27.02%
Holding in Top 10
57
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+32.56%
% of All Funds
1.52%
New
121
Increased
338
Reduced
398
Closed
67
Calls
$1.49B
Puts
$1.59B
Net Calls
-$99.4M
Net Calls Change
+$153M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$2.38B |
| 2 |
Jennison Associates
New York
|
$818M |
| 3 |
JPMorgan Chase & Co
New York
|
$1.13B |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
$297M |
| 5 |
UBS AM
Chicago,
Illinois
|
$479M |
